A Phase 1b Open-label, Multicenter Dose Escalation and Expansion Study of MT-5111 in Subjects With Previously Treated Advanced HER2-positive Solid Tumors

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Park, John (Associate Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymMT-5111_001
StatusActive
Effective start/end date13/12/21 → 12/12/26